Sayfa yüklenirken bir hata oluştu.
Teknik ekibimiz bilgilendirildi, ancak sorunun devam etmesi durumunda lütfen e-posta destek widget ile bize ulaşın.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBITDA Multiple | 5,6x - 6,1x | 5,9x |
| Selected Fwd EBITDA Multiple | 4,9x - 5,4x | 5,1x |
| Fair Value | €19,92 - €23,96 | €21,94 |
| Upside | 29,8% - 56,1% | 43,0% |
| Benchmarks | Ticker | Full Ticker |
| Core Laboratories Inc. | CLB | NYSE:CLB |
| Patterson-UTI Energy, Inc. | PTEN | NasdaqGS:PTEN |
| RPC, Inc. | RES | NYSE:RES |
| Liberty Energy Inc. | LBRT | NYSE:LBRT |
| NOV Inc. | NOV | NYSE:NOV |
| Helmerich & Payne, Inc. | HPC | DB:HPC |
| - | - | - |
| Select LTM EBITDA Multiple | |||||||
| Benchmark Companies | |||||||
| CLB | PTEN | RES | LBRT | NOV | HPC | ||
| NYSE:CLB | NasdaqGS:PTEN | NYSE:RES | NYSE:LBRT | NYSE:NOV | DB:HPC | ||
| Historical EBITDA Growth | |||||||
| 5Y CAGR | -11.7% | 17.1% | 10.5% | 26.8% | 78.5% | 1.7% | |
| 3Y CAGR | 3.9% | 87.5% | 41.6% | 109.0% | 99.1% | 132.0% | |
| Latest Twelve Months | -11.4% | -26.6% | -18.6% | -32.1% | -2.5% | 3.9% | |
| Historical EBITDA Profit Margin | |||||||
| 5 Year Average Margin | 13.3% | 21.9% | 13.9% | 14.6% | 7.8% | 21.2% | |
| Prior Fiscal Year | 14.2% | 28.4% | 22.4% | 24.8% | 12.0% | 31.9% | |
| Latest Fiscal Year | 12.8% | 22.3% | 15.7% | 20.6% | 15.3% | 30.3% | |
| Latest Twelve Months | 12.1% | 20.2% | 14.4% | 17.5% | 13.5% | 24.8% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 1.26x | 0.64x | 0.64x | 0.54x | 0.65x | 1.14x | |
| EV / LTM EBITDA | 10.4x | 3.2x | 4.4x | 3.1x | 4.8x | 4.6x | |
| EV / LTM EBIT | 13.5x | 891.6x | 16.0x | 11.0x | 7.1x | 11.6x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBITDA | 3.1x | 4.4x | 10.4x | ||||
| Historical EV / LTM EBITDA | 2.9x | 4.7x | 164.4x | ||||
| Selected EV / LTM EBITDA | 5.6x | 5.9x | 6.1x | ||||
| (x) LTM EBITDA | 850 | 850 | 850 | ||||
| (=) Implied Enterprise Value | 4,725 | 4,974 | 5,223 | ||||
| (-) Non-shareholder Claims * | (2,148) | (2,148) | (2,148) | ||||
| (=) Equity Value | 2,578 | 2,827 | 3,075 | ||||
| (/) Shares Outstanding | 99.4 | 99.4 | 99.4 | ||||
| Implied Value Range | 25.92 | 28.43 | 30.93 | ||||
| FX Rate: USD/EUR | 1.2 | 1.2 | 1.2 | Market Price | |||
| Implied Value Range (Trading Cur) | 22.14 | 24.27 | 26.41 | 15.35 | |||
| Upside / (Downside) | 44.3% | 58.2% | 72.1% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | CLB | PTEN | RES | LBRT | NOV | HPC | |
| Enterprise Value | 642 | 3,266 | 912 | 2,259 | 5,679 | 3,935 | |
| (+) Cash & Short Term Investments | 31 | 184 | 162 | 20 | 1,080 | 187 | |
| (+) Investments & Other | 0 | 0 | 0 | 86 | 178 | 102 | |
| (-) Debt | (179) | (1,287) | (81) | (517) | (2,371) | (2,335) | |
| (-) Other Liabilities | (6) | (6) | 0 | 0 | (54) | (103) | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 489 | 2,157 | 994 | 1,848 | 4,512 | 1,787 | |
| (/) Shares Outstanding | 46.9 | 385.2 | 216.9 | 162.0 | 371.4 | 99.4 | |
| Implied Stock Price | 10.43 | 5.60 | 4.58 | 11.41 | 12.15 | 17.97 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.17 | |
| Implied Stock Price (Trading Cur) | 10.43 | 5.60 | 4.58 | 11.41 | 12.15 | 15.35 | |
| Trading Currency | USD | USD | USD | USD | USD | EUR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.17 | |